Category News

Kardigan Completes Phase 2b KATALYST-AV Trial Enrollment for Ataciguat in Aortic Stenosis

Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial of Ataciguat, Advances Plans for Aortic Stenosis Development Kardigan®, Inc., a precision cardiovascular company, has announced the completion of enrollment in its Phase 2b KATALYST-AV clinical trial evaluating ataciguat in people with…

Read MoreKardigan Completes Phase 2b KATALYST-AV Trial Enrollment for Ataciguat in Aortic Stenosis

Agenus Reports Long-Term Survival Benefits with BOT+BAL in Refractory Colorectal Cancer at SITC 2026

Agenus Reports Long-Term Survival Benefits with Botensilimab and Balstilimab Combination in MSS Metastatic Colorectal Cancer at SITC 2026 Agenus Inc., a biotechnology company focused on developing innovative immuno-oncology treatments, has announced encouraging long-term survival findings from an analysis of its…

Read MoreAgenus Reports Long-Term Survival Benefits with BOT+BAL in Refractory Colorectal Cancer at SITC 2026

Global Healthy Living Foundation Highlights Advances in Myositis and Polymyalgia Rheumatica Research at ACR Convergence 2026

Global Healthy Living Foundation to Present Six Patient-Centered Research Abstracts at ACR Convergence 2026, Highlighting Myositis and PMR Research The Global Healthy Living Foundation (GHLF) has announced that it will present six accepted research abstracts at ACR Convergence 2026, the…

Read MoreGlobal Healthy Living Foundation Highlights Advances in Myositis and Polymyalgia Rheumatica Research at ACR Convergence 2026

BioLife to Highlight Innovative Oral Peptide Delivery Technology at London Life Sciences Week

BioLife Products to Showcase Patented Oral Peptide Delivery Technology at London Life Sciences Week 2026 BioLife Products Limited will present its patented oral peptide delivery technology and recent intellectual property developments at London Life Sciences Week 2026, highlighting its efforts…

Read MoreBioLife to Highlight Innovative Oral Peptide Delivery Technology at London Life Sciences Week

Imperative Care Reports Promising Safety Findings in Women with Pulmonary Embolism in First-of-Its-Kind Analysis

Imperative Care Reports Comparable Outcomes in Women and Men Following Symphony Thrombectomy for Intermediate-Risk Pulmonary Embolism Imperative Care, a medical technology company focused on advancing the treatment of thromboembolic disease, has announced new findings from a pre-specified sex-specific analysis of…

Read MoreImperative Care Reports Promising Safety Findings in Women with Pulmonary Embolism in First-of-Its-Kind Analysis

Pretzel Therapeutics Secures UK Approval to Advance PX578 Into Clinical Trials for POLG-Related Mitochondrial Disorders

Pretzel Therapeutics Receives UK MHRA Authorization for PX578 Phase 2 Trial in POLG-Mediated Mitochondrial Disease Pretzel Therapeutics, Inc., a clinical-stage biotechnology company developing a new class of medicines intended to restore mitochondrial function, improve cellular energetics and slow disease progression…

Read MorePretzel Therapeutics Secures UK Approval to Advance PX578 Into Clinical Trials for POLG-Related Mitochondrial Disorders

AHF Calls on African Nations to Strengthen Control Over Medicines Regulation

AHF Urges African Governments to Accelerate African Medicines Agency Treaty Ratification to Strengthen Pharmaceutical Independence AIDS Healthcare Foundation Calls for Regulatory Harmonisation to Expand Access to Affordable Medicines and Boost Local Pharmaceutical Manufacturing Across Africa AIDS Healthcare Foundation (AHF) is…

Read MoreAHF Calls on African Nations to Strengthen Control Over Medicines Regulation

GT Metabolic Solutions Secures Series C Growth Investment Led by J.P. Morgan Life Sciences Private Capital

GT Metabolic Solutions Secures Series C Investment from J.P. Morgan Life Sciences Private Capital to Accelerate Global Expansion GT Metabolic™ Solutions, Inc., a medical technology company developing innovative surgical devices designed to improve gastrointestinal (GI) procedures, has announced a Series…

Read MoreGT Metabolic Solutions Secures Series C Growth Investment Led by J.P. Morgan Life Sciences Private Capital

LA Times Publishing Launches Journal of Breakthroughs in Medicine & Science to Address Gaps in Scientific Publishing

LA Times Publishing Launches Journal of Breakthroughs in Medicine & Science to Advance Global Scientific Research LA Times Publishing has announced the launch of the Journal of Breakthroughs in Medicine & Science (JBMS), a peer-reviewed, open-access scientific publication designed to…

Read MoreLA Times Publishing Launches Journal of Breakthroughs in Medicine & Science to Address Gaps in Scientific Publishing